MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ncp.10733

Медицинская библиотека · Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2021

Twelve-week peptide-based formula therapy may be effective in inducing remission of active Crohn disease among women who are pregnant or preparing for pregnancy.

Yang Qingfan, Tang Jian, Ding Ni, Chao Kang, Li Miao, Huang Zicheng, Guo Huili, Chen Junrong, Zhi Min, Hu Pinjin, Gao Xiang

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Conventional treatment for Crohn disease (CD) in pregnancy includes mesalamine, thiopurine, and anti-tumor necrosis factor (TNF)-α agents. However, women may abstain because of complications, nonresponse, or potential adverse outcomes. Peptide-based formula therapy, through oral or nasogastric feeding without other food intake, is an effective and safe therapy for active CD. Herein, We confirmed the effectiveness and safety of peptide-based formula therapy for active CD in pregnant women or those preparing for pregnancy.

METHOD: Outcomes of peptide-based formula therapy to induce CD remission during pregnancy preparation and the conception period were evaluated retrospectively among 14 women. Efficacy was evaluated as the change in serum indices and inflammatory markers after 12-week treatment. Pregnancy outcomes were compared between 14 women treated with nutrition therapy and eight women using conventional CD drugs.

RESULTS

After 12 weeks, 85.7% (12 of 14) of patients treated with peptide-based formula achieved remission with a significant decrease in the CD activity index (P < .001) and high-sensitivity C-reactive protein level (P = .004). There were no effects of peptide-based formula therapy on pregnancy outcomes compared with conventional CD treatment (P > .05). Among the 12 patients who achieved CD remission with exclusive peptide-based formula therapy, 10 selected to continue total or partial peptide-based formula treatment to maintain CD remission throughout pregnancy.

CONCLUSION

Peptide-based formula therapy, without other food intake, may provide a safe and effective alternative to conventional CD drugs to induce disease remission among women during conception and pregnancy.

Для цитирования: Yang Qingfan, Tang Jian, Ding Ni, Chao Kang, Li Miao, Huang Zicheng, Guo Huili, Chen Junrong, Zhi Min, Hu Pinjin, Gao Xiang. Twelve-week peptide-based formula therapy may be effective in inducing remission of active Crohn disease among women who are pregnant or preparing for pregnancy.. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition. 2021. DOI: 10.1002/ncp.10733.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.